Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Litigation
Patents
PipCast®
PTE
Webinars

The House Appropriations Committee expresses concern over under-utilisation of low cost biosimilars

Jul 14, 2020

In its approval of the FY2021 Labor, Health and Human Services, Education and Related Agencies bill, the House Appropriations Committee has expressed concern over the under-utilisation of low cost biosimilars. The Committee has encouraged the CMS to support development and implementation of new policies which may help increase biosimilar uptake when clinically appropriate.

Print Page Mail Article